elafibranor reduces characteristics of metabolically- and drug-induced fatty liver disease in human skin stem cell-derived hepatic cells

Joost Boeckmans; Valerie Vandenbempt; Karolien Buyl; Alessandra Natale; Vera Rogiers; Joery De Kock; Tamara Vanhaecke; Robim Marcelino Rodrigues

elafibranor reduces characteristics of metabolically- and drug-induced fatty liver disease in human skin stem cell-derived hepatic cells

Joost Boeckmans, Valerie Vandenbempt, Karolien Buyl, Alessandra Natale, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Marcelino Rodrigues

Research output: Unpublished contribution to conference › Poster

Original language	English
Publication status	Published - 2018
Event	BeSSCR 2018- annual meeting - Leuven, Belgium Duration: 26 Oct 2018 → 26 Oct 2018

Conference

Conference	BeSSCR 2018- annual meeting
Country/Territory	Belgium
City	Leuven
Period	26/10/18 → 26/10/18

Handle.net

Persistent link

Cite this

@conference{7ec4f2e0e7774feba5bbb9fed1ca0f1e,

title = "elafibranor reduces characteristics of metabolically- and drug-induced fatty liver disease in human skin stem cell-derived hepatic cells",

author = "Joost Boeckmans and Valerie Vandenbempt and Karolien Buyl and Alessandra Natale and Vera Rogiers and {De Kock}, Joery and Tamara Vanhaecke and {Marcelino Rodrigues}, Robim",

year = "2018",

language = "English",

note = "BeSSCR 2018- annual meeting ; Conference date: 26-10-2018 Through 26-10-2018",

}

TY - CONF

T1 - elafibranor reduces characteristics of metabolically- and drug-induced fatty liver disease in human skin stem cell-derived hepatic cells

AU - Boeckmans, Joost

AU - Vandenbempt, Valerie

AU - Buyl, Karolien

AU - Natale, Alessandra

AU - Rogiers, Vera

AU - De Kock, Joery

AU - Vanhaecke, Tamara

AU - Marcelino Rodrigues, Robim

PY - 2018

Y1 - 2018

M3 - Poster

T2 - BeSSCR 2018- annual meeting

Y2 - 26 October 2018 through 26 October 2018

ER -